Bone Biologics (BBLG) EBITDA (2010 - 2025)
Bone Biologics (BBLG) reported EBITDA of -$733105.0 for Q4 2025, up 52.85% year-over-year from -$479614.1 in Q4 2024, and down 2.49% quarter-over-quarter from -$715274.0 in Q3 2025.
Bone Biologics (BBLG) EBITDA (2010 - 2025) Analysis & Trends
Bone Biologics (BBLG) has 16 years of EBITDA data on file, last reported at -$733105.0 in Q4 2025.
- EBITDA for Q4 2025 came in at -$733105.0, up 52.85% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.2 million (up 23.33% YoY), and the FY2025 annual result was -$3.2 million, up 23.33% from the prior year.
- EBITDA retreated to -$733105.0 in Q4 2025 per BBLG's latest filing, from -$715274.0 in the prior quarter.
- Over five years, EBITDA peaked at -$180924.0 in Q1 2021 and troughed at -$3.1 million in Q1 2023.
- A 5-year average of -$1.1 million and a median of -$856600.5 in 2024 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2024: EBITDA plunged 547.74% in 2023, then soared 73.37% in 2024.
- A 5-year view of EBITDA shows it stood at -$460482.0 in 2021, then slumped by 179.51% to -$1.3 million in 2022, then grew by 9.87% to -$1.2 million in 2023, then slumped by 34.05% to -$1.6 million in 2024, then jumped by 52.85% to -$733105.0 in 2025.
- Business Quant data shows BBLG's EBITDA at -$733105.0 in Q4 2025, -$715274.0 in Q3 2025, and -$748075.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -65.83 Mn |
| 10 | Bone Biologics | 1.47 Mn | 1.47 Mn | - | -733,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -733,105.00 |
| Sep 30, 2025 | -715,274.00 |
| Jun 30, 2025 | -748,075.00 |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -1.55 Mn |
| Sep 30, 2024 | -951,021.00 |
| Jun 30, 2024 | -809,665.00 |
| Mar 31, 2024 | -903,536.00 |
| Dec 31, 2023 | -1.16 Mn |
| Sep 30, 2023 | -2.08 Mn |
| Jun 30, 2023 | -3.04 Mn |
| Mar 31, 2023 | -3.15 Mn |
| Dec 31, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.22 Mn |
| Jun 30, 2022 | -469,304.00 |
| Mar 31, 2022 | -689,499.00 |
| Dec 31, 2021 | -460,482.00 |
| Sep 30, 2021 | -229,789.00 |
| Jun 30, 2021 | -231,881.00 |
| Mar 31, 2021 | -180,924.00 |